Lunit AI Biomarker PD-L1 Demonstrates Clinical Efficacy
A recent study revealed that with the assistance of AI, multiple pathologists showed improved consensus in analyzing PD-L1 tumor proportion scores, finding more patients eligible for immunotherapy. The study has…
